Navigation Links
Combating concussions
Date:8/28/2013

SAN DIEGO, Calif. (August 28, 2013) In the United States there are millions of sports related concussions each year, but many go undiagnosed because for some athletes, the fear of being benched trumps the fear of permanent brain damage, and there is no objective test available to accurately diagnose concussions on the sidelines.

Researchers at San Diego State University have set out to change that.

A team led by Daniel Goble, an exercise and nutritional sciences professor at SDSU, have developed software and an inexpensive balance board that can measure balance with 99 percent accuracy on the field and in the clinic. They are testing the device on SDSU's rugby team, with the hope of soon making it available worldwide to athletes of all ages and levels.

Balance tests are a primary method used to detect concussion. The current means of scoring these tests relies on the skill of athletic trainers to visually determine whether or not a concussion has occurred.

Trainers count "errors" while watching athletes stand in different foot configurations such as on one foot or with feet heel to toe when a concussion is suspected. Errors include stepping out of place or removing one's hand from one's hip and the total number is compared to a baseline test preformed preseason.

This testing method can be both subjective and inaccurate, and can easily be skewed to return a concussed athlete to the field, said Goble.

A better test

With help from the SDSU College of Engineering and the Zahn Innovation Center, Goble recently validated the balance tracking system, or B-TrackS, to assess balance before and after potential concussions.

Currently force plates, which are small, square platforms used to quantify balance, gait and other biomechanics, are the primary tools to test balance. But they can cost $10,000 per plate, which the average high school or university can't afford.

Enter the B-Trac
'/>"/>

Contact: Beth Chee
bchee@mail.sdsu.edu
619-594-4563
San Diego State University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Combating USDAs top-ranked invasive insect
2. Notre Dame research may have important implications for combating diabetes
3. Cell research opens new avenues in combating neurodegenerative diseases
4. Nearly half of veterans found with blast concussions might have hormone deficiencies
5. Computer model may help athletes and soldiers avoid brain damage and concussions
6. Health and law expert: NFL not alone in handling concussions as benign problems
7. Cognitive deficits from concussions still present after 2 months
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... the greatest risk to Europe based upon a proxy ... researchers using a ,big data, approach to scientific research. ... and Global Health ranked the top 100 pathogens affecting ... a system which, they believe, will help governments across ... of infectious diseases, including as a result of climate ...
(Date:8/27/2014)... 2014 /PRNewswire-iReach/ -- The IEEE Engineering in Medicine and ... Annual International Conference (EMBC,14), this year being held at ... Chicago, Illinois , from Tuesday, August 26 through ... and industry professionals in science, medicine, and engineering are ... This year,s conference theme is ...
(Date:8/27/2014)... is available in German . ... the most common inherited disease affecting the peripheral nervous ... Max Planck Institute of Experimental Medicine and University Medical ... cells is impaired in rats with the disease. These ... known as myelin, which facilitates the rapid transfer of ...
Breaking Biology News(10 mins):Big data approach identifies Europe's most dangerous human and domestic animal pathogens 2Global Leaders In Science, Medicine, And Engineering Gather For The 36th Annual International Conference Of The IEEE Engineering In Medicine And Biology Society, August 26-30 In Chicago 2Global Leaders In Science, Medicine, And Engineering Gather For The 36th Annual International Conference Of The IEEE Engineering In Medicine And Biology Society, August 26-30 In Chicago 3Potential therapy for incurable Charcot-Marie-Tooth disease 2
... & Children,s Hospital and the University of Adelaide, Australia, ... with high blood pressure during pregnancy and pre-term birth. ... of Obstetrics & Gynaecology, are a major step forward ... blood pressure in pregnancy. The research has been ...
... balance of nature looms prominently in the public mind these ... declining fish stocks are but a few of the issues ... is it? It depends on whom you ask, ... the School of Life Sciences specializing in biology and society. ...
... no group takes credit. The pressure on the U.S. ... the president orders an attack, but it turns out ... Things go downhill from there. , To avoid that ... with extensive nuclear expertise, headed by Stanford physicist Michael ...
Cached Biology News:Herpes virus link to complications in pregnancy 2Managing uncertainty important in ecological balance: ASU researcher 2Group led by Stanford physicist says there's an urgent need for nuclear detectives 2Group led by Stanford physicist says there's an urgent need for nuclear detectives 3
(Date:8/27/2014)... In 2013, Lawrence Livermore National ... Security LLC (LLNS), was awarded more than ... laser system for the European Union's Extreme Light ... the Czech Republic. , When commissioned to its ... " High repetition-rate Advanced Petawatt Laser System " ...
(Date:8/27/2014)... MSC , a healthcare performance improvement company advancing clinical ... Mary Beth Loesch to President and CEO. ... companies for rapid growth and market expansion, Loesch joined ... Development and Healthcare. In that role, she oversaw MSC,s ... corporate strategy and marketing. Previously, Loesch served as Senior ...
(Date:8/27/2014)... 2014 The Global and China Trifluoroacetic ... the current state of the Trifluoroacetic Acid industry in ... overview of the industry, including definitions, applications and industry ... analysis are provided with a focus on history, developments, ... between the international and Chinese situation is also offered. ...
(Date:8/27/2014)... -- Research and Markets  has announced the ... Polymer, Food & Beverage, Personal Care & Pharmaceutical) ... report to their offering. Lactic acid ... carbon atom. The main applications of lactic acid ... personal care product, and pharmaceutical industries. Lactic ...
Breaking Biology Technology:LLNL Synchs up with ELI Beamlines on Timing System 2LLNL Synchs up with ELI Beamlines on Timing System 3MSC names Mary Beth Loesch President and CEO 2Trifluoroacetic Acid Industry (Asia, Europe, North America, ROW) Analysis Report Now Available at ReportsnReports.com 2Global Lactic Acid (Biodegradable Polymer, Food & Beverage, Personal Care & Pharmaceutical) Market - Trends & Forecasts to 2019 2
... sizes and shapes, scientists now understand how they lose ... weighing any single atom. Such ultrasensitive measurements could ... and diagnostics, enabling the detection of minuscule disease-causing agents ... level. Researchers are interested in nanosized materials because ...
... ... , ... CA (Vocus) - GreenHouse announced today that on July 30, 2009 it will introduce ... a high performance ethanol fuel for cars. The first installation of the E-Fuel ...
... , , , ... Calif. and LONDON, July 27 Amgen (Nasdaq: AMGN ... companies will share commercialization of Amgen,s monoclonal antibody denosumab for postmenopausal ... product is approved in these countries. Amgen will commercialize the ...
Cached Biology Technology:1 nano-step closer to weighing a single atom 2GreenHouse Debuts the World's First E-Fuel MicroFuelerTM in Los Angeles 2GreenHouse Debuts the World's First E-Fuel MicroFuelerTM in Los Angeles 3Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO) 2Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO) 3Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO) 4Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO) 5Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO) 6Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO) 7